News

This rally wasn't just a "Santa Claus" bump; it was the culmination of a massive strategic pivot and a multi-billion dollar divestment deal that redefined the company's balance sheet in the final days of the year.

For retail investors and biotech analysts, this wasn't just "end-of-year window dressing." It was the culmination of a pivotal year where the company successfully pivoted from a reagent-dependent model to a high-growth Contract Research Organization (CRO) powerhouse.

On December 31, 2025, while much of the FTSE 100 drifted sideways in low-volume holiday trading,British American Tobacco PLC (LSE: BATS)notched a gain of approximately1%, closing the year nearGBX4,214. In a market obsessed with tech and growth, this "boring" giant’s quiet ascent wasn't an …

This deep dive breaks down the drivers behind the surge, the radical shift in their business model, and whether this is a "dead cat bounce" or a strategic rebirth.

While the broader FTSE 100 celebrated a 22% annual bull run, MobilityOne’s vertical move has captured the attention of retail investors and institutional analysts alike. Here is the deep dive into the catalysts, the business pivot, and the risks behind this year-end phenomenon.

Picton Property Income Limited (LSE:PCTN) has received buy ratings from Stifel Europe and Panmure Lliberum, with both analysts assigning a target price of GBX 90. The rating might follow the company’s release of its half-year results for the period ending 30 September 2025, which …

This wasn't just a "Santa Rally" fluke. It was the culmination of aggressive share buybacks, a massive dividend cover, and a portfolio that is finally benefiting from falling interest rates.